| Ivermectin and COVID-19: keeping rigor in times of urgency C Chaccour, F Hammann, S Ramón-García, NR Rabinovich The American journal of tropical medicine and hygiene 102 (6), 1156, 2020 | 235 | 2020 |
| The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled … C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ... EClinicalMedicine 32, 2021 | 226 | 2021 |
| Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination CJ Chaccour, KC Kobylinski, Q Bassat, T Bousema, C Drakeley, P Alonso, ... Malaria journal 12, 1-8, 2013 | 205 | 2013 |
| Effect of Ivermectin on Anopheles gambiae Mosquitoes Fed on Humans: The Potential of Oral Insecticides in Malaria Control C Chaccour, J Lines, CJM Whitty The Journal of infectious diseases 202 (1), 113-116, 2010 | 181 | 2010 |
| Developing an expanded vector control toolbox for malaria elimination GF Killeen, A Tatarsky, A Diabate, CJ Chaccour, JM Marshall, FO Okumu, ... BMJ Global Health 2 (2), e000211, 2017 | 125 | 2017 |
| Monitoring the COVID-19 epidemic in the context of widespread local transmission AL García-Basteiro, C Chaccour, C Guinovart, A Llupià, J Brew, A Trilla, ... The Lancet Respiratory Medicine 8 (5), 440-442, 2020 | 117 | 2020 |
| Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety C Chaccour, F Hammann, NR Rabinovich Malaria journal 16, 1-16, 2017 | 116 | 2017 |
| Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis P Nicolas, MF Maia, Q Bassat, KC Kobylinski, W Monteiro, NR Rabinovich, ... The Lancet Global Health 8 (1), e92-e100, 2020 | 109 | 2020 |
| Update on malaria R Varo, C Chaccour, Q Bassat Medicina Clínica (English Edition) 155 (9), 395-402, 2020 | 92 | 2020 |
| Going beyond personal protection against mosquito bites to eliminate malaria transmission: population suppression of malaria vectors that exploit both human and animal blood GF Killeen, SS Kiware, FO Okumu, ME Sinka, CL Moyes, NC Massey, ... BMJ Global Health 2 (2), e000198, 2017 | 89 | 2017 |
| The economic burden of malaria on households and the health system in a high transmission district of Mozambique S Alonso, CJ Chaccour, E Elobolobo, A Nacima, B Candrinho, ... Malaria journal 18, 1-10, 2019 | 80 | 2019 |
| Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda CJ Chaccour, NR Rabinovich, H Slater, SE Canavati, T Bousema, ... Malaria Journal 14, 1-8, 2015 | 77 | 2015 |
| Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study HC Slater, BD Foy, K Kobylinski, C Chaccour, OJ Watson, J Hellewell, ... The Lancet Infectious Diseases 20 (4), 498-508, 2020 | 64 | 2020 |
| A roadmap for the development of ivermectin as a complementary malaria vector control tool TI Roadmappers The American journal of tropical medicine and hygiene 102 (2 Suppl), 3, 2020 | 63 | 2020 |
| Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation CJ Chaccour, K Ngha’bi, G Abizanda, A Irigoyen Barrio, A Aldaz, ... Parasites & vectors 11, 1-9, 2018 | 62 | 2018 |
| Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control C Chaccour, GF Killeen Malaria journal 15, 1-2, 2016 | 60 | 2016 |
| malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication malERA Refresh Consultative Panel on Tools for Malaria Elimination PLoS medicine 14 (11), e1002455, 2017 | 59 | 2017 |
| A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current … P Jittamala, W Monteiro, MR Smit, B Pedrique, S Specht, CJ Chaccour, ... PLoS neglected tropical diseases 15 (3), e0009144, 2021 | 54 | 2021 |
| Screening for an ivermectin slow-release formulation suitable for malaria vector control C Chaccour, ÁI Barrio, AGG Royo, DM Urbistondo, H Slater, F Hammann, ... Malaria Journal 14, 1-9, 2015 | 45 | 2015 |
| Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats C Chaccour, G Abizanda, Á Irigoyen-Barrio, A Casellas, A Aldaz, ... Scientific reports 10 (1), 17073, 2020 | 41 | 2020 |
Felix HammannUniversity Hospital BernVerified email at med.unibe.ch
